Patent 10478503 was granted and assigned to University of Massachusetts on November, 2019 by the United States Patent and Trademark Office.
Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.